GENETICALLY-DETERMINED VARIABILITY IN ACETYLATION AND OXIDATION - THERAPEUTIC IMPLICATIONS

被引：185
作者：
CLARK, DWJ
机构：
来源：
DRUGS | 1985年 / 29卷 / 04期
关键词：
D O I：
10.2165/00003495-198529040-00003
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：342 / 375
页数：34
相关论文
共 230 条
[21]  
CARTWRIGHT RA, 1982, LANCET, V2, P842
[22]   DRUGS AND GENES - THERAPEUTIC IMPLICATIONS [J].
CHAPMAN, CJ .
DRUGS, 1977, 14 (02) :120-127
[23]   EVIDENCE FOR A TRIMODAL PATTERN OF ACETYLATION OF ISONIAZID IN UREMIC SUBJECTS [J].
CHAPRON, DJ ;
BLUM, MR ;
KRAMER, PA .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1978, 67 (07) :1018-1019
[24]   KINETIC DISCRIMINATION OF 3 SULFAMETHAZINE ACETYLATION PHENOTYPES [J].
CHAPRON, DJ ;
KRAMER, PA ;
MERCIK, SA .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 27 (01) :104-113
[25]   RELATIONSHIP OF SULFAMETHAZINE DISPOSITION KINETICS TO ACETYLATOR PHENOTYPE IN MAN - PRELIMINARY-STUDY [J].
CHAPRON, DJ ;
BLUM, MR .
JOURNAL OF CLINICAL PHARMACOLOGY, 1976, 16 (07) :338-344
[26]   POTENTIAL INFLUENCE OF BODY-WEIGHT ON THE CLEARANCE OF POLYMORPHICALLY ACETYLATED DRUGS [J].
CHAPRON, DJ ;
KRAMER, PA ;
MERCIK, SA .
JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 22 (5-6) :271-275
[27]  
CLARK DWJ, 1983, P U OTAGO MED SCH, V61, P30
[28]  
CLARK DWJ, 1984, CLIN EXPT PHARM PH S, V8, P67
[29]  
CLARK DWJ, 1984, BRIT J CLIN PHARM
[30]   POLYMORPHICALLY ACETYLATED AMINOGLUTETHIMIDE IN HUMANS [J].
COOMBES, RC ;
FOSTER, AB ;
HARLAND, SJ ;
JARMAN, M ;
NICE, EC .
BRITISH JOURNAL OF CANCER, 1982, 46 (03) :340-345
12345678910